←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Pharmacology, Early Phase Trials
Amita Patnaik
MD
🏢START Center for Cancer Care🌐USA
Associate Director of Clinical Research
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Amita Patnaik is a seasoned phase I investigator who has led numerous first-in-human oncology trials at START. Her work has contributed to the development of multiple approved targeted agents and immune checkpoint inhibitors. She emphasizes pharmacokinetic and pharmacodynamic rigor in early phase studies.
Share:
🧪Research Fields 研究领域
phase I trials
first-in-human studies
PK/PD analysis
drug development
investigational therapeutics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Amita Patnaik 的研究动态
Follow Amita Patnaik's research updates
留下邮箱，当我们发布与 Amita Patnaik（START Center for Cancer Care）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment